<DOC>
	<DOC>NCT00650611</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of oral ziprasidone in children and teens with psychotic disorders</brief_summary>
	<brief_title>A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Children and teens with Bipolar I Disorder (manic or mixed), schizophrenia or schizoaffective disorder Willingness to discontinue all antipsychotic medications during the study period Patients who are clinically stable on treatments that are well tolerated Substanceinduced psychotic disorders</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>